1.
Clin Infect Dis
; 71(11): 2962-2964, 2020 12 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32392332
RESUMO
Different dosage regimens of hydroxychloroquine are used to manage coronavirus disease 2019 (COVID-19) patients, without information on the pharmacokinetics in this population. Blood samples (nâ =â 101) were collected from 57 COVID-19 patients for 7 days, and concentrations were compared with simulated kinetic profiles. Hydroxychloroquine exposure is low and cannot be predicted by other populations.